Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

8.21
+0.01000.12%
Post-market: 8.210.00000.00%16:41 EDT
Volume:751.10K
Turnover:6.19M
Market Cap:1.12B
PE:205.25
High:8.38
Open:8.21
Low:8.20
Close:8.20
Loading ...

Stock Track | Aurinia Pharmaceuticals Soars on Stellar Q3 Results and Strategic Restructuring

Stock Track
·
07 Nov 2024

Unusually active option classes on open November 7th

TIPRANKS
·
07 Nov 2024

Aurinia Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary

Reuters
·
07 Nov 2024

Aurinia Pharmaceuticals Shares up 7.4% After Co Announces Restructuring, Workforce Cut

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals (AUPH) Q3 Earnings and Revenues Beat Estimates

Zacks
·
07 Nov 2024

BUZZ-Aurinia Pharmaceuticals rises on job cuts, restructuring

Reuters
·
07 Nov 2024

Aurinia Pharmaceuticals Shares up 9.1% Premarket After Co Announces Restructuring, Workforce Cut

THOMSON REUTERS
·
07 Nov 2024

Aurinia: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring

TIPRANKS
·
07 Nov 2024

BRIEF-Aurinia Pharma Reports Q3 And Nine-Months 2024 Results, Announces Restructuring To Focus On Lupkynis And AUR200

Reuters
·
07 Nov 2024

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Business Wire
·
07 Nov 2024

Stock Track | Aurinia Pharmaceuticals Soars on Blowout Q3 Earnings Beat

Stock Track
·
07 Nov 2024

Aurinia Pharmaceuticals Q3 2024 Adj EPS $0.10 Beats $0.01 Estimate, Sales $67.80M Beat $57.69M Estimate

Benzinga
·
07 Nov 2024

BRIEF-Aurinia Pharmaceuticals Q3 Operating Income USD 11.748 Million

Reuters
·
07 Nov 2024

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued Lupkynis® Growth and Aur200 Development

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals Inc - to Reduce Workforce by Approximately 45% in Restructuring

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals Inc - Expects Q4 Restructuring Charge of $15-$19 Mln

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals Inc - Reiterates 2024 Net Product Revenue Guidance of $210-$220 Mln

THOMSON REUTERS
·
07 Nov 2024

Aurinia Pharmaceuticals Q3 Pretax Profit USD 14.807 Million

THOMSON REUTERS
·
07 Nov 2024